Beacon Biosignals

Healthcare Software · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

80 Revere St Apt 10, Boston, Massachuset...

Website

beacon.bio

Revenue

$21 Million

Industry

Healthcare Software Software Business Services Research & Development
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
3
3
2
2

About Beacon Biosignals

Beacon Biosignals, is a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain. Beacon Biosignals was founded in 2019 and is based in Boston, Massachusetts.Explore more
Beacon Biosignals's Social MediaPopular SearchesBeacon Biosignals IncBeacon BiosignalsDreemSIC Code 73,737NAICS Code 54,541Show more

Beacon Biosignals Org Chart

Jacob Donoghue, Chief Executive Officer & Co-Founder at Beacon Biosignals
United States flag for contact location.

Chief Executive Officer & Co-Founder

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
Jarrett Revels, Chief Technology Officer & Co-Founder at Beacon Biosignals
United States flag for contact location.

Chief Technology Officer & Co-Founder

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AF
United States flag for contact location.

Senior Director, RWD Solutions

PhoneEmail
LE
United States flag for contact location.

Director, Product, Wearable Devices

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Beacon Biosignals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Beacon Biosignals

Compare insights from companies similar to Beacon Biosignals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Beacon Biosignals

$21M
51-200
Private
$210M
2019
Jacob Donoghue, Chief Executive Officer & Co-Founder at Beacon Biosignals
Jacob DonoghueCEO & Co-Founder
$27.6M
11-50
Private
-
2018
ML
Minh LeTeam Lead, Dream Project
<$5M
51-200
Private
-
2017
RH
Rachel HuAdministrator
<$5M
51-200
Private
-
2014
AM
Abbas-Ali MolviAssistant Manager
<$5M
11-50
Private
-
-
Tengfei Xiao, Chief Technology Officer at GV20 Oncotherapy
Tengfei XiaoChief Technology Officer
<$5M
51-200
Private
-
2018
MI
Mohamed IsamelChief Technology Officer
Illustration of an envelope

Company Profile Activity

i

Among all Software companies

Low Activity

High Activity

Activity Insights

Beacon Biosignals is experiencing very low activity levels compared to other companies in the Software sector.

What does this means?

Beacon Biosignals is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Beacon Biosignals.

Beacon Biosignals financials insights

Gather financial insights about Beacon Biosignals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2021

Series A

$27M

2025

Series B

$86M

2026

Series B

$97M

See All Beacon Biosignals's Financials Insights

Beacon Biosignals Tech Stack

A closer look at the technologies used by Beacon Biosignals

Most Recent Scoops

Open Position
Open Position
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Person-Based
Person-Based
See more scoops

Top Healthcare Software Companies

Frequently Asked Questions Regarding Beacon Biosignals

What is Beacon Biosignals's official website?
Beacon Biosignals's official website is beacon.bio
What is Beacon Biosignals's Revenue?
Beacon Biosignals's revenue is $21 Million
What is Beacon Biosignals's SIC code?
Beacon Biosignals's SIC: 73,737
What is Beacon Biosignals's NAICS code?
Beacon Biosignals's NAICS: 54,541
How many employees does Beacon Biosignals have?
Beacon Biosignals has 51-200 employees
What industry does Beacon Biosignals belong to?
Beacon Biosignals is in the industry of: Healthcare Software, Software, Business Services
What is Beacon Biosignals competition?
Beacon Biosignals top competitors include: Neurotechnology Exploration Team, Big Vision, GV20 Oncotherapy, Artificial Intelligence Technology Solutions
What companies has Beacon Biosignals acquired?
Beacon Biosignals has acquired the companies: Dreem
What technology does Beacon Biosignals use?
Some of the popular technologies that Beacon Biosignals uses are: Google Cloud Web Serving, Google Cloud Platform, Databricks, Kubernetes
Who is the CTO of Beacon Biosignals?
Beacon Biosignals's CTO is Jarrett Revels
What does Beacon Biosignals do?

Beacon Biosignals, is a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain. Beacon Biosignals was founded in 2019 and is based in Boston, Massachusetts.... Read More

What are Beacon Biosignals social media links?
Beacon Biosignals Linkedin page Beacon Biosignals Twitter page
Who invested in Beacon Biosignals?
Beacon Biosignals has 18 investors including Catalio Capital Management, Indicator Ventures Select I, General Catalyst and Casdin Capital.
Is Beacon Biosignals a public company?
Beacon Biosignals is private company therefore does not currently have an official ticker symbol
See more information about Beacon Biosignals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.